Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,419 | 61 | 96.9% |
| Education | $109.83 | 2 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Laboratories Inc | $1,038 | 18 | $0 (2018) |
| Alcon Vision LLC | $520.05 | 5 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $365.53 | 9 | $0 (2024) |
| Alimera Sciences, Inc. | $256.14 | 3 | $0 (2022) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $249.85 | 2 | $0 (2019) |
| Johnson & Johnson Surgical Vision, Inc. | $159.82 | 2 | $0 (2019) |
| Horizon Therapeutics plc | $141.08 | 1 | $0 (2022) |
| ABBVIE INC. | $126.38 | 5 | $0 (2024) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $121.05 | 1 | $0 (2018) |
| Allergan Inc. | $119.75 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $437.79 | 17 | ABBVIE INC. ($126.38) |
| 2023 | $91.30 | 4 | Apellis Pharmaceuticals, Inc. ($27.87) |
| 2022 | $288.43 | 7 | Horizon Therapeutics plc ($141.08) |
| 2019 | $1,332 | 12 | Alcon Vision LLC ($496.06) |
| 2018 | $1,195 | 20 | Alcon Laboratories Inc ($1,038) |
| 2017 | $184.81 | 3 | Regeneron Healthcare Solutions, Inc. ($122.79) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: EYE CARE | ||||||
| 11/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/13/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Ophthalmology | ||||||
| 10/10/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Ophthalmology | ||||||
| 10/08/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Ophthalmology | ||||||
| 09/27/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: EYE CARE | ||||||
| 09/25/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/17/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: EYE CARE | ||||||
| 08/22/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Education | In-kind items and services | $20.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/31/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: Ophthalmology | ||||||
| 05/29/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Ophthalmology | ||||||
| 04/20/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: EYE CARE | ||||||
| 03/12/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $27.79 | General |
| Category: Ophthalmology | ||||||
| 03/02/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/27/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: EYE CARE | ||||||
| 02/21/2024 | Coherus Biosciences Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: Ophthalmology | ||||||
| 02/14/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: Ophthalmology | ||||||
| 08/02/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/15/2023 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Ophthalmology | ||||||
| 05/03/2023 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Ophthalmology | ||||||
| 03/08/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $27.87 | General |
| Category: Ophthalmology | ||||||
| 12/10/2022 | Bausch & Lomb Americas Inc. | XIPERE (Drug), VISUDYNE | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Ophthalmology | ||||||
| 09/07/2022 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Ophthalmology | ||||||
| 08/24/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/27/2022 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $13.00 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,171 | 2,753 | $1.3M | $458,539 |
| 2022 | 12 | 572 | 970 | $376,563 | $112,568 |
| 2021 | 5 | 134 | 141 | $79,265 | $19,883 |
| 2020 | 14 | 654 | 807 | $399,777 | $109,944 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 41 | 421 | $630,000 | $286,623 | 45.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 268 | 702 | $269,568 | $67,409 | 25.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 83 | 343 | $131,445 | $31,859 | 24.2% |
| 92134 | Imaging of retina | Office | 2023 | 291 | 681 | $84,444 | $21,417 | 25.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 120 | 120 | $54,720 | $12,060 | 22.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 89 | 89 | $44,500 | $10,708 | 24.1% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 54 | 142 | $23,100 | $9,996 | 43.3% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 37 | 42 | $56,028 | $7,584 | 13.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $17,212 | $4,573 | 26.6% |
| 92250 | Photography of the retina | Office | 2023 | 132 | 143 | $17,160 | $4,026 | 23.5% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 19 | 33 | $4,800 | $1,194 | 24.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 11 | 11 | $3,927 | $1,088 | 27.7% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 12 | 53 | $78,000 | $36,906 | 47.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 120 | 245 | $80,721 | $24,278 | 30.1% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 118 | 118 | $46,100 | $12,288 | 26.7% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2022 | 11 | 11 | $44,298 | $10,470 | 23.6% |
| 67028 | Injection of drug into eye | Office | 2022 | 30 | 110 | $50,460 | $9,976 | 19.8% |
| 92134 | Imaging of retina | Office | 2022 | 125 | 225 | $26,290 | $7,079 | 26.9% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 22 | 43 | $6,900 | $2,999 | 43.5% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2022 | 15 | 15 | $15,668 | $2,658 | 17.0% |
| 92250 | Photography of the retina | Office | 2022 | 79 | 84 | $15,696 | $2,249 | 14.3% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 16 | 38 | $5,700 | $1,953 | 34.3% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 11 | 11 | $3,567 | $1,095 | 30.7% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 13 | 17 | $3,163 | $618.18 | 19.5% |
| 67042 | Removal of membrane from the retina, pars plana approach with removal of internal limiting membrane of retina | Facility | 2021 | 45 | 45 | $27,000 | $6,996 | 25.9% |
About Dr. Luv Patel, M.D
Dr. Luv Patel, M.D is a Ophthalmology healthcare provider based in Southlake, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2015. The National Provider Identifier (NPI) number assigned to this provider is 1689061442.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luv Patel, M.D has received a total of $3,529 in payments from pharmaceutical and medical device companies, with $437.79 received in 2024. These payments were reported across 63 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,419).
As a Medicare-enrolled provider, Patel has provided services to 2,531 Medicare beneficiaries, totaling 4,671 services with total Medicare billing of $700,934. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Southlake, TX
- Active Since 04/20/2015
- Last Updated 12/01/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1689061442
Products in Payments
- AcrySof (Device) $1,007
- OZURDEX (Drug) $246.13
- Iluvien (Drug) $243.14
- EYLEA (Biological) $186.43
- CyPass (Device) $163.94
- EYLEA AFLIBERCEPT INJECTION (Biological) $158.37
- Centurion (Device) $156.31
- TEPEZZA (Drug) $141.08
- ENVISTA (Device) $139.32
- Cimerli (Biological) $131.60
- STELLARIS (Device) $110.53
- Tecnis 1-piece IOL (Device) $97.80
- Syfovre (Drug) $78.62
- XIPERE (Drug) $67.45
- SYMPHONY (Device) $62.02
- Vabysmo (Drug) $53.49
- PROKERA (Device) $46.44
- Izervay (Drug) $30.88
- Rocklatan (Drug) $23.99
- SUSVIMO (Drug) $22.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Southlake
Jawad Qureshi, Md, MD
Ophthalmology — Payments: $4,082
Musa Abdelaziz, Md, MD
Ophthalmology — Payments: $3,627
Dr. Martin Reinke, M.d, M.D
Ophthalmology — Payments: $3,559
Omar Moinuddin, Md, MD
Ophthalmology — Payments: $3,193
Dr. Robert Lyons, Md, MD
Ophthalmology — Payments: $641.45